Article | December 15, 2023

Evaluating Biologics CDMOs: Tips For Crafting An RFP

By Andrew Handorf, Director, Proposals, Scorpius BioManufacturing


The pharmaceutical landscape is shifting, and for innovators developing cutting-edge biologics, finding the right Contract Development and Manufacturing Organization (CDMO) is more critical than ever. However, with diverse therapeutic landscapes and evolving go-to-market strategies, traditional RFPs fall short. This article unveils the secrets to crafting a compelling RFP that attracts the appropriate biologics CDMO partner, one capable of navigating the complexities of your program and propelling you to success.

Delve deep into the transformative power of a well-designed RFP, one that transcends mere cost-efficiency to unearth hidden needs and bridge critical expertise gaps within your organization. Learn how to assemble a multidisciplinary team, conduct insightful analyses, and pinpoint the specific technical requirements that will unlock your program's full potential.

A comprehensive RFP should provide a vivid description of your program and therapeutic, outlining your timeline, budget, and selection criteria. Transparency is a crucial element in fostering trust, enabling potential CDMOs to tailor their proposals to your unique needs and mitigate potential risks.

Whether you're a seasoned innovator or an emerging biotherapeutic player, explore the tools and insights necessary to navigate the maze of RFP creation. By investing in a well-crafted document, you unlock a world of possibilities, paving the way for a seamless collaboration that accelerates your journey to market.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma